XTX Topco’s LAVA Therapeutics LVTX Stock Holding History

XTX Topco’s Portfolio LVTX Stock Details LVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-21,727	Closed	-$33.9K	–	3593
2025 Q3	$33.9K	Buy	+21,727	New	+$32.5K	﹤0.01%	2240
2025 Q2	–	Sell	-24,307	Closed	-$30.9K	–	2833
2025 Q1	$30.9K	Buy	+24,307	New	+$27.1K	﹤0.01%	2072
2024 Q3	–	Sell	-30,807	Closed	-$55.5K	–	2377
2024 Q2	$55.5K	Buy	+30,807	New	+$81.3K	﹤0.01%	1499

XTX Topco's LVTX Position: Q4 2025 in Review

XTX Topco sold out of LAVA Therapeutics (LVTX) in Q4 2025, closing a stake of 21,727 shares — an estimated $33.9K sold.

XTX Topco first reported a position in LVTX in Q2 2024 and held it in 3 quarters. The position peaked at $55.5K in Q2 2024. 0 funds tracked by Wall St. Rank hold LVTX as of Q4 2025.

XTX Topco reported no remaining LAVA Therapeutics position as of Q4 2025 after selling out during the quarter.
XTX Topco sold 21,727 LAVA Therapeutics shares in Q4 2025, an estimated $33.9K.
XTX Topco first reported a position in LAVA Therapeutics in Q2 2024 and held it in 3 quarters.
XTX Topco's LAVA Therapeutics position peaked at $55.5K in Q2 2024.
0 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.